ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
1-Year Return
2.5%
This Quarter Return
+7.74%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$167M
AUM Growth
-$28.1M
(-14%)
Cap. Flow
-$27.2M
Cap. Flow
% of AUM
-16.23%
Top 10 Holdings %
Top 10 Hldgs %
42.83%
Holding
127
New
32
Increased
5
Reduced
15
Closed
34
Top Buys
| 1 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$4.58M |
| 2 |
Penumbra
PEN
|
+$4.46M |
| 3 |
Alphatec Holdings
ATEC
|
+$4.21M |
| 4 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$3.18M |
| 5 |
Varex Imaging
VREX
|
+$3M |
Top Sells
| 1 |
Akero Therapeutics
AKRO
|
+$6.85M |
| 2 |
PEPL
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
|
+$6.47M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.29M |
| 4 |
Rhythm Pharmaceuticals
RYTM
|
+$4.95M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$4.32M |
Sector Composition
| 1 | Healthcare | 91.74% |
| 2 | Financials | 3.92% |
| 3 | Technology | 0.91% |
| 4 | Communication Services | 0.54% |
| 5 | Materials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tilray
TLRY
$1.23B
| – | – |
0
| – | – |
|
127
Tandem Diabetes Care
TNDM
$845M
| – | – |
-90,000
| Closed | -$4.05M |
|